FDA Rejects Schizophrenia Drug; Psilocybin for Anxiety; Solitary Confinement Lawsuit

(MedPage Today) -- The FDA rejected the investigational drug roluperidone for the treatment of negative symptoms in patients with schizophrenia and called for at least one more positive study, according to developer Minerva Neurosciences. Six...
Source: MedPage Today Psychiatry - Category: Psychiatry Source Type: news